Literature DB >> 20153140

Cognitive decline in schizophrenia from childhood to midlife: a 33-year longitudinal birth cohort study.

William S Kremen1, Sophia Vinogradov, John H Poole, Catherine A Schaefer, Raymond F Deicken, Pam Factor-Litvak, Alan S Brown.   

Abstract

BACKGROUND: We examined cognitive deficits before and after onset of schizophrenia in a longitudinal study that: 1) covers a long time interval; 2) minimizes test unreliability by including the identical measure at both childhood and post-onset cognitive assessments; and 3) minimizes bias by utilizing a population-based sample in which participants were selected neither for signs of illness in childhood nor for being at risk for schizophrenia.
METHODS: Participants in the present study, Developmental Insult and Brain Anomaly in Schizophrenia (DIBS), were ascertained from an earlier epidemiologic study conducted in Oakland, CA. The original version of the Peabody Picture Vocabulary Test (PPVT), a test of receptive vocabulary, was administered at age 5 or 9 and repeated as part of the DIBS study at an average age of 40. There were 10 DIBS cases with DSM-IV schizophrenia or schizoaffective disorder and 15 demographically similar DIBS controls with both child and adult PPVT scores.
RESULTS: Cases scored significantly lower than controls in childhood (d=0.95) and adulthood (d=1.67). Residualized scores indicating the number of SDs above or below one's predicted adult score revealed a mean case-control difference of -1.51SDs, consistent with significant relative decline over time among the cases (p<0.0013).
CONCLUSIONS: In this prospective study, individuals who developed adult schizophrenia manifested impaired receptive vocabulary during childhood and further relative deterioration (or lack of expected improvement) between childhood and midlife. Limitations should also be acknowledged, including the small sample size and the fact that we cannot be certain when the continued deterioration took place. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20153140      PMCID: PMC3184642          DOI: 10.1016/j.schres.2010.01.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers.

Authors:  R Fucetola; L J Seidman; W S Kremen; S V Faraone; J M Goldstein; M T Tsuang
Journal:  Biol Psychiatry       Date:  2000-07-15       Impact factor: 13.382

2.  Schizophrenia and the myth of intellectual decline.

Authors:  A J Russell; J C Munro; P B Jones; D R Hemsley; R M Murray
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

3.  Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients.

Authors:  P D Harvey; J M Silverman; R C Mohs; M Parrella; L White; P Powchik; M Davidson; K L Davis
Journal:  Biol Psychiatry       Date:  1999-01-01       Impact factor: 13.382

4.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

5.  The design of the prenatal determinants of schizophrenia study.

Authors:  E S Susser; C A Schaefer; A S Brown; M D Begg; R J Wyatt
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

6.  Incidence and cumulative risk of treated schizophrenia in the prenatal determinants of schizophrenia study.

Authors:  M A Bresnahan; A S Brown; C A Schaefer; M D Begg; R J Wyatt; E S Susser
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

7.  Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study.

Authors:  Larry J Seidman; Stephen L Buka; Jill M Goldstein; Ming T Tsuang
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

8.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Authors:  J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich
Journal:  Arch Gen Psychiatry       Date:  1994-11

9.  Premorbid IQ in schizophrenia: a meta-analytic review.

Authors:  Kristen A Woodberry; Anthony J Giuliano; Larry J Seidman
Journal:  Am J Psychiatry       Date:  2008-04-15       Impact factor: 18.112

10.  Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

Authors:  Terry E Goldberg; Robert S Goldman; Katherine E Burdick; Anil K Malhotra; Todd Lencz; Raman C Patel; Margaret G Woerner; Nina R Schooler; John M Kane; Delbert G Robinson
Journal:  Arch Gen Psychiatry       Date:  2007-10
View more
  22 in total

1.  Non-synonymous variants in the AMACR gene are associated with schizophrenia.

Authors:  Irina N Bespalova; Martina Durner; Benjamin P Ritter; Gary W Angelo; Enrique Rossy-Fullana; Jose Carrion-Baralt; James Schmeidler; Jeremy M Silverman
Journal:  Schizophr Res       Date:  2010-09-26       Impact factor: 4.939

2.  Birth weight and neurocognition in schizophrenia spectrum disorders.

Authors:  David Freedman; Yuanyuan Bao; William S Kremen; Sophia Vinogradov; Ian W McKeague; Alan S Brown
Journal:  Schizophr Bull       Date:  2012-02-29       Impact factor: 9.306

Review 3.  The developmental course of executive functioning in schizophrenia.

Authors:  David Freedman; Alan S Brown
Journal:  Int J Dev Neurosci       Date:  2010-11-24       Impact factor: 2.457

4.  Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time.

Authors:  Michel Maziade; Nancie Rouleau; Caroline Cellard; Marco Battaglia; Thomas Paccalet; Isabel Moreau; Valérie Gagnon; Nathalie Gingras; Cecilia Marino; Elsa Gilbert; Marc-André Roy; Chantal Mérette
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

5.  Rethinking schizophrenia.

Authors:  Thomas R Insel
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 6.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

7.  Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study.

Authors:  Madeline H Meier; Avshalom Caspi; Abraham Reichenberg; Richard S E Keefe; Helen L Fisher; HonaLee Harrington; Renate Houts; Richie Poulton; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2014-01       Impact factor: 18.112

8.  A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.

Authors:  Kate E Valerio; Katherine G Jonas; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  Psychiatry Res       Date:  2021-07-14       Impact factor: 11.225

Review 9.  Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses.

Authors:  Kristin R Laurens; Luming Luo; Sandra L Matheson; Vaughan J Carr; Alessandra Raudino; Felicity Harris; Melissa J Green
Journal:  BMC Psychiatry       Date:  2015-08-25       Impact factor: 3.630

Review 10.  Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice.

Authors:  Joanne L Doherty; Michael J Owen
Journal:  Genome Med       Date:  2014-04-28       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.